Plexxikon Inc. announced that dosing began in the first of two Phase 1 clinical trials with PLX5622, a novel, oral and highly selective Fms inhibitor, targeted for the treatment of rheumatoid arthritis…
Category: News
Provectus Pharmaceuticals, Inc. Completes Patient Accrual And Treatment For Phase 1 Trial Of PV-10 For Liver Cancer
Provectus Pharmaceuticals, Inc. (OTCBB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has completed patient accrual and treatment of all subjects in its Phase 1 clinical trial of PV-10 for liver cancer….
H3 Biomedicine Launches To Discover And Develop Next Generation Cancer Treatments
H3 Biomedicine Inc. announced that it has launched research and development operations in Cambridge, Massachusetts. H3 Biomedicine will undertake a comprehensive approach to breakthrough oncology treatments based on two primary principles: 1)…
Medtronic Announces Global Launch Of The CD HORIZON(R) SOLERA™ Spinal System
Continuing a stream of recent advancements for stabilization of the spine, Medtronic, Inc. (NYSE: MDT) announced both the release of its CD HORIZON® SOLERA™ Spinal System in the U.S. and a limited…
Courageous Young Mother Battles Mesothelioma; Advocates For Total Ban On Asbestos Use
On April 1 – 3, people from across the globe will gather for the Asbestos Disease Awareness Organization’s (ADAO) 7th Annual International Asbestos Awareness Conference, Asbestos: Impact on Public Heath, Environment, and…
Receptos Initiates Clinical Trials For S1P1 Agonist Program, Aimed At Multiple Sclerosis
Receptos, Inc., announced that their highly selective sphingosine-1-phosphate receptor 1 (S1P1) agonist, RPC1063, has been administered to the first subject in a single-ascending and multiple-ascending dose design Phase 1 clinical safety study….
SCH conducts health and safety course
The Supreme Council of Health (SCH) has started a four-day course with the Chartered Institute of Environmental Health (CIEH) based in UK. It is being held for Level 3 Award in Health…
Early Successful Readout Of Tarceva Study In A Distinct Form Of Lung Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc.,…
Doctors Groups Strive To Get Critically Needed Medical Services Back Into Flood-Affected Towns, Australia
Key Rural Health Organisations are banding together to help their flood affected colleagues get back up and running after many lost their entire surgeries to the floods. Dr Paul Mara, president of…
AMA Urges Governments To Adopt Food Labelling Recommendations, Australia
The AMA urged all Australian governments to act quickly and adopt the key recommendations of the Labelling Logic report. The Labelling Logic report was prepared by the Independent Review of Food Labelling…
Exploring Memory Training As A Strategy For Addiction Treatment
Virginia Tech Carilion Research Institute faculty member leads study resulting in new insight on rehabilitating brain function in addicts People with addictions to stimulants tend to choose instant gratification or a smaller…
Bacteria A Possible Cause Of Preterm Births
The type of bacteria that colonize the placenta during pregnancy could be associated with preterm birth and other developmental problems in newborns according to research published in the current issue of the…
Protein Related To Aging Holds Breast Cancer Clues
The most common type of breast cancer in older women – estrogen and progesterone receptor (ER/PR) positive breast cancer – has been linked to a protein that fends off aging-related cellular damage….
Improved Prediction Of Breast Cancer Outcomes: New Test Discovered
Gene expression signature identified that can accurately assess which patients are at risk of relapse. Researchers from McGill University’s Rosalind and Morris Goodman Cancer Research Centre (GCRC), the Research Institute of the…
Link To Increased Atherosclerosis Risk In Lupus Patients Revealed By Researchers
Researchers in China have demonstrated interferon-alpha (IFN-a) is associated with increased risk of atherosclerosis in patients with systemic lupus erythematosus (SLE). For the first time, IFN-a priming was shown to promote lipid…